Phase I - II studies | |||
2 completed studies: | |||
Indication |
Study phase
Specific population |
Sites |
Patients |
Radiopharmaceuticals (oncology) |
Phase I
|
1 Sites |
21 |
Radiopharmaceuticals (oncology) |
Phase II | 1 Sites | 42 |